Posted December 18, 2020
This report for professionals by the UK’s MHRA gives more insight into what we know so far. The report has more detail on the seniors than our Friday update and is equally concerning. Keeping in mind that the large second trial only included healthy community-dwelling seniors — not your typical nursing home population — these quotes suggest that the data on safety and efficacy for our frail, elderly is very limited: Read more.